Table 3 Clinical characteristics according to ultrasound grade in GD patients.

From: The relationship between ultrasound findings and thyroid function in children and adolescent autoimmune diffuse thyroid diseases

Variable

Total (N = 64)

G1 (N = 0, 0%)

G2 (N = 8, 12.5%)

G3 (N = 22,34.4%)

G4 (N = 34, 53.1%)

 

Age (year)

16 ± 3.1

 

17 ± 2.2

15 ± 3.8

17 ± 2.5

0..862

Male

23 (36%)

 

2 (25%)

4 (18.2%)

17 (50%)

0.951

Female

41 (64%)

 

6 (75%)

18 (81.8%)

17 (50%)

 

Thyroid function

 1

 

0 (0%)

0 (0%)

0 (0%)

2 (100%)

 

 2

 

0 (0%)

0 (0%)

2 (%)

1 (%)

 

 3

 

0 (0%)

5 (%)

1 (%)

1 (%)

0.39

 4

 

0 (0%)

0 (0%)

5 (%)

0 (0%)

 

 5

 

0 (0%)

3 (%)

14 (%)

30 (%)

 

TSH

 

NA

0.49 ± 0.64

0.58 ± 1.73

1.58 ± 6.98

 

TSH (hypo-euthyroid)

9.44 ± 13.79

NA

NA

4.01 ± 3.18

13.46 ± 17.99

NA

TSH (hyper-euthyroid)

0.13 ± 0.39

NA

0.49 ± 0.64

0.05 ± 0.11

0.08 ± 0.39

0.637

TGAb

338.88 ± 636.41

NA

332.43 ± 716.86

166.52 ± 179.87

460.12 ± 817.11

0.569

TPOAb

1433.10 ± 1579.12

NA

1266.33 ± 1476.47

1224.47 ± 1476.80

1652.51 ± 1710.85

0.753

TRAb

30.64 ± 27.84

NA

1.7 ± 1.06

22.09 ± 28.07

40.54 ± 25.18

0.047

  1. G, grade; N, number of patients; TSH, thyroid stimulating hormone; TG, antithyroglobulin antibodies; TPO, antithyroid peroxidase antibodies; TRAb, TSH receptor antibodies; NA, not assessable.